UMR INSERM 1092, Université de Limoges, National Reference Center For Herpesviruses, Bacteriology-Virology-Hygiene Department, CHU Limoges, 2 ave ML King, 87000, Limoges, France; bioMérieux, 138 rue Louis Pasteur, Parc technologique Delta Sud, 09340, Verniolle, France.
Nephrology and Transplantation Department, CHU Limoges, 2 ave ML King, 87000, Limoges, France.
J Clin Virol. 2018 Aug;105:118-127. doi: 10.1016/j.jcv.2018.06.010. Epub 2018 Jun 11.
Torque teno viruses (TTV) are small DNA viruses whose replication is closely linked to immune status. A growing number of publications underlined the potential of TTV viral load as an indicator of immunosuppression.
To demonstrate the analytical performance of the first standardized RUO (Research Use Only) assay to detect and quantify human TTV DNA in whole blood and plasma.
We established analytical performances for TTV load measurement in various populations. The TTV kinetics were followed in kidney recipients. TTV viral load was analyzed on whole blood samples from 42 kidney recipients follow-up, 53 kidney deceased donors and 31 healthy volunteers.
The qPCR TTV assay detects the most prevalent human TTV genotypes and does not cross react with other viruses. Limit of detection was 2.2 log copies/mL in whole blood and plasma, linearity and precision were demonstrated over the range 1.61 to 10.61 log copies/mL in whole blood. Prevalence of TTV DNA in blood differed significantly among groups: 45% in healthy volunteers, 74% in donors and 83% in kidney recipients. In kidney recipients, early TTV kinetics were comparable to those previously observed with in-house assays in other transplant settings: viral load increased from an average of 4.3 log to 7.9 log copies/mL within the first 75 days post transplantation.
This TTV assay showed high analytical sensitivity, specificity, linearity and precision. It is a useful standardized tool to further evaluate TTV load as a biomarker of immune status that could improve individual treatment strategy.
Torque teno 病毒(TTV)是一种小型 DNA 病毒,其复制与免疫状态密切相关。越来越多的研究强调了 TTV 病毒载量作为免疫抑制标志物的潜力。
展示首个用于检测和定量全血和血浆中人 TTV DNA 的标准化研究用试剂(RUO)检测方法的分析性能。
我们建立了用于各种人群中 TTV 载量测量的分析性能。我们还研究了肾移植受者的 TTV 动力学。分析了 42 例肾移植受者随访、53 例肾死亡供者和 31 例健康志愿者的全血样本中的 TTV 病毒载量。
qPCR TTV 检测法可检测最常见的人类 TTV 基因型,与其他病毒无交叉反应。全血和血浆中的检测限为 2.2 对数拷贝/mL,全血中 1.61 至 10.61 对数拷贝/mL 的范围内可证明线性和精密度。血液中 TTV DNA 的流行率在各组之间存在显著差异:健康志愿者中为 45%,供者中为 74%,肾移植受者中为 83%。在肾移植受者中,早期 TTV 动力学与之前在其他移植环境中使用内部检测法观察到的情况相似:病毒载量在移植后 75 天内从平均 4.3 对数增加到 7.9 对数拷贝/mL。
该 TTV 检测法具有较高的分析灵敏度、特异性、线性和精密度。它是一种有用的标准化工具,可进一步评估 TTV 载量作为免疫状态的生物标志物,从而改善个体治疗策略。